Vinay Shah - 07 Apr 2026 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Reporting relationship: Chief Financial Officer
Issuer ticker: ADIL
Reported as of: 07 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Apr 2026, 17:00:06 UTC
Prior SEC filing: 02 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ John Martin, Attorney-in-fact for Vinay Shah

Key filing fact

Vinay Shah filed Form 4 for ADIAL PHARMACEUTICALS, INC. (ADIL) on 09 Apr 2026.

Key facts

This page summarizes Vinay Shah's Form 4 filing for ADIAL PHARMACEUTICALS, INC. (ADIL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 09 Apr 2026, 17:00.

Change

Previous filing in this sequence was filed on 02 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001753078 Primary reporting owner

Shah Vinay

Relationship: Chief Financial Officer
Address: 4870 SADLER ROAD, STE 300, GLEN ALLENVA
Signature: /s/ John Martin, Attorney-in-fact for Vinay Shah
Signature date: 09 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADIL transaction

Common Stock

Award

Transaction value
Shares: +17,325
Change %
Price: $0.000000^*
Shares after: 17,325
Date: 07 Apr 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date.